Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: bupivacaine

« Back to Dashboard

Summary for Generic Name: bupivacaine

Tradenames:13
Patents:2
Applicants:8
NDAs:36
Drug Master File Entries: see list10
Suppliers: see list1

Pharmacology for Ingredient: bupivacaine

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia

Clinical Trials for: bupivacaine

2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula
Status: Recruiting Condition: Infraclavicular Brachial Plexus Block

Bupivacaine Pain Pumps to Decrease Mastectomy Post-Operative Pain
Status: Not yet recruiting Condition: Pain

ED50 and ED95 of Intrathecal Bupivacaine With or Without Epinephrine for Total Knee Replacement Arthroplasty
Status: Completed Condition: Spinal Anesthesia; Total Knee Replacement Arthroplasty

Plasma Concentrations of Bupivacaine After Peri-articular Injection in Total Knee Arthroplasty
Status: Completed Condition: Serum Bupivacaine Level; Periarticular Block; Total Knee Arthroplasty

Efficacy of Interscalene Brachial Plexus Block With Liposomal Bupivacaine for Arthroscopic Shoulder Surgery
Status: Recruiting Condition: Shoulder Pain; Rotator Cuff Tear

Efficacy of Single Injection Femoral Nerve Block With Liposomal Bupivacaine for Total Knee Arthroplasty
Status: Not yet recruiting Condition: Total Knee Arthroplasty

Analgesic Efficacy of Two Concentrations of Bupivacaine in Women in Labor
Status: Completed Condition: Obstetric Pain

Determination of the Effective Volume of 0.125% Bupivacaine-fentanyl 5mcg/mL in Labour Epidurals
Status: Completed Condition: Pain

Comparison of Standard and Minidose Spinal Anesthesia for Cesarean Section Operation Using Marcaine Spinal 0.5% Heavy
Status: Not yet recruiting Condition: Cesarean Section; Anesthesia, Spinal; Local Anaesthetics Causing Adverse Effects in Therapeutic Use

Bupivacaine Pharmacokinetics Following TAP Block
Status: Recruiting Condition: Transversus Abdominis Plane Block

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
SENSORCAINE
bupivacaine hydrochloride
INJECTABLE;INJECTION070552May 21, 1986RXNo<disabled><disabled>
Fresenius Kabi Usa
SENSORCAINE
bupivacaine hydrochloride
INJECTABLE;INJECTION070553May 21, 1986RXNo<disabled><disabled>
Pacira Pharms Inc
EXPAREL
bupivacaine
INJECTABLE, LIPOSOMAL;INJECTION022496Oct 28, 2011DISCNNo<disabled><disabled>
Hospira
BUPIVACAINE HYDROCHLORIDE
bupivacaine hydrochloride
INJECTABLE;INJECTION070584Feb 17, 1986RXNo<disabled><disabled>
Hospira
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
bupivacaine hydrochloride; epinephrine
INJECTABLE;INJECTION071170Jun 16, 1988RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc